Treatment Planning Systems And Advanced Image Processing Market Size, Share & Trends Analysis Report By Component, By Technique, By Application (Adaptive Radiotherapy, Dose Accumulation), By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global treatment planning systems and advanced image processing market size was valued at USD 1.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2030. The growing prevalence of cancer and increasing medical imaging procedures drive the demand for treatment planning systems which in turn is anticipated to drive the market growth over the forecast years. The growing demand for innovative and accurate cancer treatment using advanced image processing technology is further supporting to the rising penetration of the market all over the globe. Evolvinghealthcare ITinfrastructure and growing adoption ofMachine Learning(ML) andArtificial Intelligence(AI) for oncology treatment practices is also fueling market growth.

此外,增加市场pl的焦点ayers to invest in the innovation of advanced technology in order to hold a strong position in the global market is also anticipated to accelerate market growth. For instance, the Atlanta-based digital health IT company OncoLens announced in January 2021 to raise USD 7.3 million to capitalize on its position in the cancer treatment planning solutions market.

迅速增加,癌症t both regional and global levels is boosting the demand for advanced and innovative treatment practices. For instance, as per 2020 Globocan estimates, about 10.0 million cancer-related mortalities, and approximate 19.3 million new cancer cases were diagnosed globally. Breast cancer is the most common type of cancer contributing about 11.7% of all cancer types followed by lung cancer (11.4%), colorectal cancer (10.0%), prostate cancer (7.3%), and stomach cancer (5.6%) respectively. In addition, the growing prevalence of cancer coupled with the demand for adequate treatment plans for better clinical outcomes is also anticipated to accelerate the growth of the market for treatment planning systems and advanced image processing. For instance, as per the GLOBOCAN statistics, it is estimated that the global burden will be over 28.4 million new cancer cases by 2040, which is a 47.0% rise from 2020.

COVID-19 treatment planning systems and advanced image processing market impact: an increase of 5.8% market growth between 2019 and 2020

Pandemic Impact	Post COVID Outlook
The treatment planning systems and advanced image processing market grew at a rate of 5.8% from 2019 to 2020.	The market is estimated to witness a year-on-year growth between 6.7% to 7.6% in the next 5 years
The rapid rise of Covid-19 infection has increased the demand for healthcare digitalization and improved IT infrastructure. In addition, growing complications due to cancer and continuous lockdown and travel bans accelerated the treatment planning and image processing software’s adoption.	Increasing prevalence of cancer and the growing adoption of advanced image processing and treatment planning software for radiology procedure decision making and treating cancer with high accuracy.
The surge in the adoption of digital health platforms and the shortage of radiologists supported the growth of the market.	Growing market consolidation activities by the market players such as collaboration, acquisition, new product launch to cater to the growing demand for treatment planning systems, and advanced image processing solutions are also anticipated to accelerate the market growth during post COVID period.

Furthermore, the growing popularity of radiotherapy for the diagnosis and treatment of cancer is one of the prominent factors for the growth of the market for treatment planning systems and advanced image processing. According to an article published by the American Cancer Society in June 2019, about half (49%) of the early-stage breast cancer patients undergo Breast-conserving Surgery (BCS) with adjuvant radiation therapy for the treatment due to its increased efficiency. In addition, several government initiatives to develop modern healthcare infrastructure for the oncology diagnosis using advanced medical imaging technology are further anticipated to accelerate market growth over the years. For instance, in April 2018, Elekta received Mexican government tender approval to provide advanced radiation therapy equipment and sophisticated software to Mexico's largest public health care provider Instituto Mexicano del Seguro Social (IMSS).

The increasing adoption of artificial intelligence and machine learning by the market players to develop oncology software solutions to enhance treatment plans, diagnosis, and management of cancer is further supporting to the growth of the market for treatment planning systems and advanced image processing. In addition, the increasing initiatives and projects were undertaken to develop health information learning platforms to support improved quality of care for oncology which is also anticipated to boost market growth. For instance, as of March 2020, the CancerLinQ a big-data platform for oncology developed by CancerLinQ LLC, included data of 1,426,015 cancer patients from 63 organizations in the U.S. Similarly, in May 2019, the new American College of Radiology Data Science Institute (ACR DSI) launched AI-LAB, a free software platform allows radiologists to participate in the validation creation, and artificial intelligence (AI) use for health care.

Furthermore, widespread adoption of the treatment planning systems and its increased accessibility by the radiotherapy centers coupled with strategic collaborations among key market players to develop technologically advanced solutions, in turn, anticipated propelling market growth over the years. For example, Accuray Inc. in 2020, collaborated with multiple hospitals in Japan and provided them with Radixact System with Synchrony Technology. These technologies are expected to provide advanced cancer treatments to more patients throughout Japan with increasing accuracy. In addition, the increasing development of machine learning and AI-enabled treatment planning systems for cancer prognosis is also supporting the revenue growth of the market for treatment planning systems and advanced image processing. For instance, in 2019, RaySearch Laboratories demonstrated the new release of RayCare 3A oncology information system and RayStation 9A innovative treatment planning system in the American Association of Physicists in Medicine (AAPM), U.S.

The growing COVID-19 pandemic has encouraged the adoption of digital platforms in healthcare facilities for online patient monitoring and cost optimization. The increasing development of Machine learning and AI-based software for better treatment planning to manage cancer with high accuracy further accelerated the growth of the market during the COVID-19 period. Furthermore, the growing prevalence of cancer and its complications and the travel restrictions due to COVID-19 have boosted the demand for scalable healthcare IT infrastructure to manage and maintain patient health. In addition, the surge in adoption of advanced image processing and treatment planning software for radiology procedure decision-making further supported market growth in this period.

Component Insights

The treatment planning software segment accounted for the highest revenue share of 88.1% in 2021. This high segment share is attributable to the growing prevalence of cancer and increasing demand for accurate and advanced oncology therapy solutions. The increasing awareness regarding the adoption of treatment planning software solutions due to its efficiency in cancer treatment using radiotherapy is further propelling the growth of the segment. In addition, advancements in healthcare infrastructure, increasing public-private partnerships, and preference to use software solutions over conventional practice are some of the major factors attributable to the high revenue share of the segment. For instance, Fujitsu in February 2021 collaborated with the researchers of the University of Toronto to develop technology to streamline radiation treatment plans for brain tumors and arteriovenous malformations procedures.

Furthermore, the auto-contouring software segment under treatment planning software solutions registered the highest market share of 31.1% in 2021. Manual contouring lacks efficiency, accuracy, standardization, thereby restraining the adoption and increasing the demand for auto-contouring solutions for radiotherapy. In addition, increasing product launches also shape the segment growth. For instance, in May 2020, Mirada Medical launched the online version of auto-contouring software ‘DLCExpert’ for the treatment of cancer during the COVID-19 pandemic.

However, the highest growth rate is the advanced image processing software segment during the forecast period. The increasing demand for radiology procedures for the diagnosis and treatment of cancer and the growing adoption of advanced medical imaging solutions are anticipated to boost the segment growth over the years. The increasing number of imaging modalities and growing modern radiology facilities all over the globe with AI-incorporated advanced image processing software are further anticipated to accelerate the growth of the segment. In addition, the shortage of trained radiology professionals is further boosting the demand for advanced image processing solutions.

Technique Insights

The in-room imaging segment accounted for the highest revenue share of 55.4% in 2021. The growing technological advancement in radiology procedures to treat cancer and provide real-time image data is one of the major factors responsible for the high share of the segment. To provide accurate and precise treatment solutions, there is an increasing demand for in-room imaging processes. This process includes capturing pictures during the time of therapy and sharing across to radiologists to overcome challenges such as tissue radiotherapy toxicity, and dosage volume standardization.

The benefits and growing adoption of in-room imaging processes to reduce dosage toxicity, improve target localization, improved tumor control, and shorter treatment course is further supporting the growth of the segment. In addition, the continuous product launch activities by the manufacturers for the in-room imaging processes are also anticipated to boost the segment growth. For instance, Canon Medical Systems in February 2019 launched Acquilion Lightning 80, Aquilion Prime, and Acquilion LB with radiotherapy package to improve CT in-room imaging for better oncology planning.

高增长率预计从3 d图像reconstruction segment over the forecast years. The increase in adoption of 3D image reconstruction due to its benefits in the treatment planning processes for dosage distribution planning, optimization of therapy process realization, applicator selection, and minimizing collateral tissue damage is anticipated to drive the growth rate of the segment over the years. The medical imaging oncology treatment process involves 3D image projections using reconstruction techniques from multiple images to create three-dimensional models to help doctors in faster and more accurate clinical diagnoses. The growing demand for fast and accurate cancer treatment practices to tackle the global cancer prevalence is one of the major factors anticipated to drive the growth of the 3D image reconstruction segment.

Application Insights

In 2021, the validation of the image registration segment accounted for the highest revenue share of 27.4%. This share of the segment is attributable to the importance of image datasets creation and its registration for a treatment planning process. The medical image registration constructs real-time image datasets from anatomical atlases and multiple image modalities to help in efficient and accurate dose planning. These solutions conduct validations on dosage accumulation, dose distribution, and contours through the developed imaged datasets during cancer therapy. Varian Medical Systems and RaySearch Laboratories are the two key players developing platforms for image registration validation.

However, the fastest growth rate is expected from the adaptive radiotherapy segment during the forecast years. Adaptive radiotherapy is widely used for treating neck, head, and stomach cancers. The increasing adoption of treatment planning systems and image processing solutions in adaptive radiotherapy to correct morphological variations is expected to accelerate the segment growth over the forecast period. In addition, the growing number of oncology radiotherapy facilities positively impacts the segment growth. Moreover, the increasing development of advanced treatment plan solutions by the manufacturers further supports the segment growth. For instance, in September 2019 Varian an oncology technology developer introduced artificial intelligence (AI)-powered Ethos Solution designed to deliver adaptive radiotherapy treatment.

Regional Insights

North America accounted for the highest revenue share of 38.5% in the global treatment planning systems and advanced image processing market in 2021. This share of the region is attributable to the increasing healthcare IT infrastructure and rapid adoption of advanced image processing and treatment planning solutions. In addition, the presence of sophisticated cancer research institutes coupled with improved healthcare infrastructure also is the major factor driving the market in this region. The growing demand for advanced, effective, and accurate cancer treatment practices has also boosted the growth of the market for treatment planning systems and advanced image processing in North America.

However, in Asia Pacific, the market for treatment planning systems and advanced image processing is anticipated to witness a high CAGR over the forecast period owing to the widespread healthcare IT solutions adoption and constant healthcare advancements in many developing economies such as India and China. The growing prevalence of cancer and increasing healthcare expenditure by both private and public players is supporting market growth. For instance, the new cancer cases estimated by Globocan 2020 in the Asia Pacific is about 9,503,710. Furthermore, initiatives are undertaken by the government and private organizations to spread awareness and accelerate advanced image processing solution adoption for cancer treatment are also anticipated to drive the growth of the market over the forecast years.

Key Companies & Market Share Insights

Key market players are focusing on launching advanced treatment planning solutions to expand their portfolio and hold a strong position in the market for treatment planning systems and advanced image processing. For instance, in April 2019, synchrony motion tracking and correction technology was launched by Accuray Inc. to use in its Radixact System, which enables real-time tracking, correction, and visualization for tumor motion during treatment. Similarly, in September 2020 Elekta received the EU Medical Device Regulation certificate for its linear accelerator (linac) portfolio to treat a wide variety of cancers.

市场的顶级制造商接受治疗planning systems and advanced image processing are also looking forward to strategic acquisition and collaboration with other companies to expand their global presence and market share. For instance, Accuray Inc. in October 2020 collaborated with Brainlab for the expansion of the Accuray CyberKnife treatment platform to help improve patient outcomes in neuro-radiosurgery. Similarly, ViewRay Inc. in April 2020 collaborated with VieCure an AI informatics company to drive personalized cancer care by educating oncology practices. Some of the prominent players in the treatment planning systems and advanced image processing market include:

• Accuray Incorporated

• Elekta

• Philips Healthcare

• RaySearch Laboratories

• Varian Medical Systems

• Brainlab

• Prowess Inc.

• DOSIsoft SA

• ViewRay Inc.

• MIM Software Inc.

Treatment Planning Systems And Advanced Image Processing Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 1.9 billion
Revenue forecast in 2030	USD 3.5 billion
Growth rate	CAGR of 8.3% from 2022 to 2030
Base year for estimation	2021
Actual estimates/Historical data	2016 - 2020
Forecast period	2022 - 2030
Quantitative units	Revenue in USD million and CAGR from 2022 to 2030
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Component, technique, application, region
Regional scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope	U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE
Key companies profiled	Accuray Incorporatd; Elekta; Koninklijke Philips NV; RaySearch Laboratories; Varian Medical Systems; Brainlab; Prowess, Inc.; DOSIsoft SA; Viewray, Inc.; MIM Software, Inc.
Customization scope	Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.
价格和购买该俱乐部ns	Avail customized purchase options to meet your exact research needs.Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global treatment planning systems and advanced image processing market report on the basis of component, technique, application, and region:

• Component Outlook (Revenue, USDMillion, 2016 - 2030)

  • Advanced Image Processing Software

  • Treatment Planning Software

    • Auto-Contouring Software

    • Multi-Modality Software

    • PET/CT Deformable Software

    • DICOM-RT Software

• Technique Outlook (Revenue, USD Million, 2016 - 2030)

  • 3D Image Reconstruction

  • In-Room Imaging

  • Image Registration using Graphics Processor Unit

• Application Outlook (Revenue, USD Million, 2016 - 2030)

  • Adaptive Radiotherapy

  • Online Monitoring

  • Tracking

  • Dose Accumulation

  • Validation of Image Registration

• Regional Outlook (Revenue, USDMillion, 2016 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • Spain

    • France

    • Italy

    • Russia

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • UAE

    • South Africa